Search results for "CYTOKINE"

showing 10 items of 1787 documents

Relationship of transforming growth factor-beta(1) with tumour necrosis factor-alpha and endothelial activation in patients with stable renal transpl…

2008

SUMMARY: Aim:  To evaluate whether or not transforming growth factor-beta1 is related to inflammation markers and to intercellular and vascular cell adhesion molecules in patients with stable renal transplantation. Methods:  Serum concentrations of transforming growth factor-beta1, tumour necrosis factor-alpha, C-reactive protein and adhesion molecules were analysed in 33 renal transplanted patients, 33 patients with chronic renal insufficiency (matched to the transplanted group for level of renal function), and 33 hypertensives with normal renal function. anova, Student's t-test and simple regression analysis were used to analyse the data. Results:  Transplanted patients showed higher valu…

AdultMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentIntercellular Adhesion Molecule-1Renal functionVascular Cell Adhesion Molecule-1Transforming Growth Factor beta1Internal medicinemedicineHumansRenal Insufficiency ChronicKidney transplantationInflammationbiologyCell adhesion moleculebusiness.industryTumor Necrosis Factor-alphaC-reactive proteinGraft SurvivalGeneral MedicineTransforming growth factor betaMiddle Agedmedicine.diseaseIntercellular Adhesion Molecule-1Kidney TransplantationTransplantationEndocrinologyCytokineC-Reactive ProteinCross-Sectional StudiesNephrologyCase-Control StudiesHypertensionbiology.proteinEndothelium VascularbusinessBiomarkersGlomerular Filtration RateNephrology (Carlton, Vic.)
researchProduct

Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemia

1993

It was the aim of this study to investigate the antileukemic activities of recombinant interferon beta (rIFN beta) in chronic-phase CML in vitro and in vivo. Nine patients in the early chronic-phase of CML were treated in a phase-II trial with escalating doses of rIFN beta. In parallel, antiproliferative and immunomodulatory activities of rIFN beta and rIFN alpha 2b were studied in vitro. rIFN beta exhibited a significantly higher antiproliferative activity on hematopoietic progenitor cells of CML patients in vitro than rIFN alpha 2b. In contrast, only very limited clinical antileukemic efficacy of rIFN beta was observed. None of the patients achieved a complete or partial hematologic respo…

AdultMalemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentAlpha (ethology)Interferon alpha-2PharmacologyNeopterinIn vivoInternal medicineHumansMedicineBeta (finance)AgedHematologyDose-Response Relationship Drugbusiness.industryInterferon-alphaInterferon-betaHematologyGeneral MedicineImmunotherapyMiddle AgedReceptor antagonistmedicine.diseaseBiopterinRecombinant ProteinsCytokineGenesLeukemia Myeloid Chronic-PhaseImmunologyFemaleInterferonsbeta 2-MicroglobulinbusinessChronic myelogenous leukemiaAnnals of Hematology
researchProduct

Effects of mud-pack treatment on plasma cytokine and soluble adhesion molecule levels in healthy volunteers

2001

Abstract Background : The suggested hypothesis of a direct anti-inflammatory property of mud-pack treatment has led us to speculate that its action on the cytokine network might counteract the heat-stress-related effects on platelet and endothelial cell function often reported following hot-spring baths. Therefore, the present study was designed to investigate the effects of a cycle of 12 daily mud-pack treatments on bio-humoral markers of inflammation, as well as on markers of in vivo platelet and/or endothelial cell activation, in plasma samples obtained from healthy volunteers. Methods : Blood samples were obtained before ( T 0 ), at the end of the first treatment ( T 1 ) and after a cyc…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentClinical BiochemistryHematocritBiochemistrymud-pack treatmentBlood cellLeukocyte CountIn vivoReference ValuesInternal medicinemedicineHumansPlateletadhesion moleculesmedicine.diagnostic_testCell adhesion moleculeChemistryInterleukin-6Platelet CountTumor Necrosis Factor-alphaMud TherapyBiochemistry (medical)General MedicineHyperthermia InducedMiddle AgedPlatelet ActivationcytokinesEndothelial stem cellP-Selectinmedicine.anatomical_structureEndocrinologyCytokineHematocritHemostasisImmunologyadhesion molecules; cytokines; mud-pack treatmentFemaleEndothelium VascularE-SelectinCell Adhesion MoleculesBiomarkersInterleukin-1
researchProduct

Impact of Different Texture of Polypropylene Mesh on the Inflammatory Response

2008

Over the past decade, hernia surgery has undergone a considerable transformation with the use of prosthetic materials. The most used polypropylene meshes induce a rapid acute inflammatory response followed by chronic foreign body reaction. Many factors influence this response such as density, size, physical characteristics, different texture and porosity of each biomaterial. The aim of this study is to assess whether the implant of monofilament or multifilament meshes, in the inguinal hernioplasty, determine a different inflammatory response. Thirty-two male patients were included in the study and were randomly divided into two groups. In the first group (MO) inguinal hernioplasty was perf…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentImmunologyUrologyHernia InguinalPolypropylenesProsthesisLeukocyte CountBasal (phylogenetics)medicineHumansImmunology and AllergyHerniaInflammationPharmacologyPain Postoperativebusiness.industryForeign-Body ReactionInterleukinVenous bloodMiddle AgedSurgical Meshmedicine.diseasePeripheralC-Reactive ProteinCytokinealpha 1-AntitrypsinCytokinesImplantbusinessInternational Journal of Immunopathology and Pharmacology
researchProduct

Protein supplementation increases postexercise plasma myostatin concentration after 8 weeks of resistance training in young physically active subject…

2015

Abstract Myostatin (MSTN) is a negative regulator of muscle growth even if some studies have shown a counterintuitive positive correlation between MSTN and muscle mass (MM). Our aim was to investigate the influence of 2 months of resistance training (RT) and diets with different protein contents on plasma MSTN, interleukin 1 beta (IL-1β), interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α), and insulin-like growth factor 1 (IGF-1). Eighteen healthy volunteers were randomly divided in two groups: high protein (HP) and normal protein (NP) groups. Different protein diet contents were 1.8 and 0.85 g of protein·kg bw(-1)·day(-1) for HP and NP, respectively. Subjects underwent 8 weeks of st…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentInterleukin-1betanutritional supplementMedicine (miscellaneous)MyostatinMuscle hypertrophyYoung AdultInternal medicinecytokinemedicineHumansInsulin-Like Growth Factor IMuscle SkeletalInterleukin 6Nutrition and DieteticsexercisebiologyInterleukin-6Tumor Necrosis Factor-alphaGrowth factorResistance trainingResistance TrainingProtein supplementationEndocrinologymyostatinDietary SupplementsBody Compositionbiology.proteinLean body massTumor necrosis factor alphaDietary ProteinsFull Communicationsdiet
researchProduct

Cytokine modifications after tension-free hernioplasty or open conventional inguinal hernia repair

2001

Abstract Background: The purpose of this study was to evaluate the involvement of proinflammatory cytokines (interferon-γ [INF-γ], interleukin [IL]-6) and anti-inflammatory cytokines (IL-4, IL-l0, IL-13) in patients undergoing Lichtenstein tension-free hernioplasty (LH) using polypropylene prosthetic materials or conventional Bassini hernia (BH) repair. Methods: Thirty-five male patients (age range 25 to 60 years) with unilateral inguinal hernia without complications or recurrence were included in this study. Randomly, patients underwent conventional operation and had their inguinal hernia repair performed with polypropylene mesh. Peripheral venous blood samples were collected 24 hours prio…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentUrologyHernia InguinalPolypropylenesPeripheral blood mononuclear cellProinflammatory cytokineInterferon-gammaBlood plasmamedicineHumansHerniaAnalysis of Variancebusiness.industryInterleukinsInterleukinGeneral MedicineMiddle AgedSurgical Meshmedicine.diseaseSurgeryInguinal herniaCytokineSurgical meshSurgerybusinessThe American Journal of Surgery
researchProduct

Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology

2019

Background: Erythropoietin (EPO) is a cytokine primarily involved in the regulation of erythropoiesis. In response to hypoxia–ischemia, hypoxia-inducible factor 1 induces EPO production, which, in turn, inhibits apoptosis of erythroid progenitor cells. By the same mechanism and acting through other signaling pathways, EPO exerts neuroprotective effects. Increased resistance to hypoxia and decreased apoptosis are thought to be important mechanisms for tumor progression, including malignant glioma. Because recent studies have demonstrated that EPO and its receptor (EPOR) are expressed in several tumors and can promote tumor growth, in the present study, we investigated EPO and EPOR expression…

AdultMalemedicine.medical_treatmentBlotting WesternErythropoietin receptor03 medical and health sciences0302 clinical medicineGliomaCell Line TumormedicineReceptors ErythropoietinAnimalsHumansErythropoietinAgedPlatelet Endothelial Cell Adhesion Moleculebusiness.industryBrain NeoplasmsGliomaMiddle Agedmedicine.diseaseImmunohistochemistryRats Inbred F344Recombinant ProteinsErythropoietin receptorTumor BurdenPlatelet Endothelial Cell Adhesion Molecule-1Disease Models AnimalCytokineKi-67 AntigenApoptosisErythropoietinTumor progressionErythropoietin; Erythropoietin receptor; Glioma030220 oncology & carcinogenesisCancer researchErythropoiesisSurgeryFemaleNeurology (clinical)business030217 neurology & neurosurgeryNeoplasm Transplantationmedicine.drugErythropoietin Erythropoietin receptor Glioma
researchProduct

Induction of the cytokine TWEAK and its receptor Fn14 in ischemic stroke.

2008

Stroke outcome is determined by delayed neuronal cell death and edema formation. TWEAK, a cytokine of the TNF superfamily, and its membrane receptor Fn14 promote ischemia-induced neuronal apoptosis and leakage of the blood-brain barrier. Both TWEAK and Fn14 are upregulated in experimental stroke models. In this study, we investigated whether TWEAK and Fn14 are upregulated in stroke patients. We measured serum concentrations of TWEAK in stroke patients and matched control subjects by ELISA. Expression of Fn14 in the brain was evaluated by real-time RT-PCR and immunohistochemistry. TWEAK serum concentrations were elevated in stroke patients. In autopsy samples, we found elevated mRNA levels o…

AdultMalemedicine.medical_treatmentEnzyme-Linked Immunosorbent AssayFunctional LateralityReceptors Tumor Necrosis FactorCerebral edemaBrain ischemiaCell surface receptorMedicineHumanscardiovascular diseasesRNA MessengerReceptorStrokeCytokine TWEAKAgedAged 80 and overbusiness.industryCerebral infarctionBrainCytokine TWEAKMiddle Agedmedicine.diseaseUp-RegulationStrokeCytokineNeurologyTWEAK ReceptorCase-Control StudiesImmunologyTumor Necrosis FactorsFemaleNeurology (clinical)businessJournal of the neurological sciences
researchProduct

Analysis of cytokine and specific antibody profiles in hydatid patients with primary infection and relapse of disease

1998

We studied in vitro cytokine production by peripheral blood mononuclear cells (PBMC) from patients with primary and recurrent hydatid disease when cells were incubated with mitogen (PHA) and antigen from hydatid cyst fluid (HCFAg); levels of specific IgE, IgG4 and eosinophil counts were also measured in sera. When specifically stimulated, PBMC from patients produced higher levels of IL-2 (P < 0.02), IFN-γ (P < 0.0028) and IL-5 (P < 0.01) than those from uninfected donors, whereas IL-10 levels were comparable. Notably, IL-5 was also produced in higher levels (P < 0.01) by PBMC from patients when incubated with PHA. The IL-5:IFN-γ ratio was significantly greater (P < 0.02) when measured in re…

AdultMalemedicine.medical_treatmentImmunologyAntibodies HelminthBlood DonorsCell CountStimulationDiseaseImmunoglobulin EPeripheral blood mononuclear cellAntigenEchinococcosisRecurrencemedicineAnimalsHumansPhytohemagglutininsCells CulturedAgedbiologybusiness.industryMiddle AgedEosinophilIn vitroEosinophilsmedicine.anatomical_structureCytokineAntigens HelminthImmunologyLeukocytes Mononuclearbiology.proteinCytokinesCattleFemaleParasitologyMitogensbusinessCell DivisionParasite Immunology
researchProduct

Serum levels of interleukin-18 and s-ICAM-1 in patients affected by psoriasis: preliminary considerations.

2003

Objective To find new aspects of the systemic involvement of the Immune System in psoriasis, we determined serum levels of interleukin-18 (IL-18) (Th1-inducing factor cytokine), CD30 (Th2 marker) and sICAM-1 (adhesion molecule). In addition we evaluated the correlation between these molecules and psoriasis area and severity index (PASI). Background Psoriasis is associated to an overexpression of Th1 cytokines and a relative underexpression of Th2 cytokines. IL-18 plays an important role in inducing Th1 response because it is a potent inductor of synthesis of IFN-γ, TNF and other mediators. The two major sources of IL-18 are monocytes and macrophages but also human keratinocytes constitutive…

AdultMalemedicine.medical_treatmentKi-1 AntigenDermatologySeverity of Illness IndexImmune systemPsoriasis Area and Severity IndexPsoriasisMedicineHumansPsoriasisICAM-1business.industryCase-control studyInterleukin-18medicine.diseaseIntercellular Adhesion Molecule-1Infectious DiseasesCytokineCase-Control StudiesImmunologyInterleukin 18Tumor necrosis factor alphaFemalebusinessJournal of the European Academy of Dermatology and Venereology : JEADV
researchProduct